Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >MediSan >Year 2013, Issue 06

Olivera EÁL, Reyes SRE, Soria PR, Gracia SEA, Salas FA
Eisenmenger syndrome in an elderly patient
MediSan 2013; 17 (06)

Language: Español
References: 10
Page: 1001-1007
PDF: 239.28 Kb.

Full text


A case report of a 62 year-old patient with cyanotic congenital heart disease, who was admitted to the Cardiology Department of "Saturnino Lora" Provincial Teaching Clinical Surgical Hospital of Santiago de Cuba to present with shortness of breath was described. On physical examination cyanosis, complete arrhythmia and systolic murmur in mesocardium with signs of refractory heart failure of the right side were found. Complementary tests confirmed the diagnosis of Eisenmenger syndrome attributable to ventricular septal defect. Despite receiving medication she made bad progress and died. It is rare for patients with this complication survive into old age.

Key words: elderly, cyanotic congenital heart disease, Eisenmenger syndrome, ventricular septal defect, Cardiology Department.


  1. Kaemmerer H, Mebus S, Schulze-Neick I, Eicken A, Trindade PT, Hager A, et al. The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options. Curr Cardiol Rev. 2010;6(4):343-55.

  2. Mebus S, Schulze-Neick I, Oechslin E, Niwa K, Trindade PT, Hager A, et al. The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment-Study Results. Curr Cardiol Rev. Nov 2010;6(4):356-62.

  3. Salehian O, Schwerzmann M, Rambihar S, Silver D, Siu S, Webb G, Liu P. Left ventricular dysfunction and mortality in adult patients with Eisenmenger syndrome. Congenit Heart Dis. 2007;2(3):156-64.

  4. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebocontrolled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006; 151(4):851.

  5. Schulze Neick I, Gilbert N, Ewert R, Witt C, Gruenig E, Enke B. Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy. Am Heart J. 2005; 150(4):716.

  6. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol. 2003; 42(11):1982-7.

  7. Sandoval J, Aguirre JS, Pulido T, Martinez-Guerra ML, Santos E, Alvarado P. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med. 2001; 164(9):1682-7.

  8. Van De Bruaene A, Delcroix M, Pasquet A, et al. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J. 2011;32(22):2790-9.

  9. Baumgartner H et al. Guía de práctica clínica del la ESC para el manejo de cardiopatías congénitas en el adulto (nueva versión 2010). Rev Esp Cardiol. 2010; 63(12):1484-59.

  10. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Mortality in adult congenital heart disease. European Heart J. 2010; 31:2020-9.

>Journals >MediSan >Year 2013, Issue 06

· Journal Index 
· Links 

Copyright 2019